Know Cancer

or
forgot password

Colonoscopic Screening in First-degree Relatives of Hong Kong Chinese Patients With Sporadic Colorectal Cancer: a Cohort Study With Case Control Analysis


N/A
40 Years
70 Years
Open (Enrolling)
Both
Colorectal Cancer Screening

Thank you

Trial Information

Colonoscopic Screening in First-degree Relatives of Hong Kong Chinese Patients With Sporadic Colorectal Cancer: a Cohort Study With Case Control Analysis


Colorectal cancer is a second commonest tumor in Hong Kong and the second commonest cause of
cancer related death. About 1 in 23 males will develop colorectal cancer in his life time.
The disease tends to cluster in families. This may be a combination of factors including
shared genes, shared environment or chance. Known familial syndromes occur in only about 5%
of cases. The majority is not well understood and labelled sporadic colorectal cancer. The
screening strategy in families of subjects with colorectal cancer has not been defined.
Colonoscopy is among the most sensitive and specific screening tool for colorectal neoplasm.
The current study determines the prevalence of adenomas among first degree relatives of
patients diagnosed with colorectal cancer. To quantify risk in this cohort, a case control
analysis is used. The prevalence of the cohort is compared to that of a control population.
The control group consists of relatives of patients with normal colonoscopic findings during
the same study period.


Inclusion Criteria:



- First degree relatives (age >40 and <70) of individuals affected with sporadic
colorectal cancer (those not associated with inflammatory bowel disease, familial
adenomatous polyposis or HNPCC syndrome).

Exclusion Criteria:

- A family history compatible with that of Hereditary Non-polyposis Colon Cancer
(HNPCC) based on the Amsterdam criteria [Table 5].

- Known Familial Adenomatous Polyposis (FAP) syndrome

- Patients and relatives with known inflammatory bowel disease

- Relatives that have received colonoscopy examinations in the past 5 years [details of
colonoscopic examinations will be sought and information on colonic neoplasms
recorded]. Those who have had barium enema examinations are eligible for trial
inclusion as barium examinations often have low sensitivity and specificity for
adenomas (around 70% respectively)

- Severe cardio-pulmonary or other medical co-morbidities that preclude safe
colonoscopic examination

Type of Study:

Observational

Study Design:

Observational Model: Case Control, Time Perspective: Prospective

Outcome Measure:

To find the prevalence of adenomas and advanced neoplasms of the first degree relatives

Outcome Time Frame:

7 years

Safety Issue:

No

Principal Investigator

James Y Lau, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Prince of Wales Hospital

Authority:

Hong Kong: Department of Health

Study ID:

FDR

NCT ID:

NCT00164944

Start Date:

April 2004

Completion Date:

Related Keywords:

  • Colorectal Cancer Screening
  • Colonoscopy
  • First degree relatives
  • Colorectal Neoplasms

Name

Location